Holen Sie sich die Stockscreener-App
394.53
0.71%
-2.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt VRTX?
Forum
Prognose
Aktiensplit
Vertex Pharmaceuticals Inc Aktie (VRTX) Neueste Nachrichten
Voya Investment Management LLC Acquires 128,432 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Swedbank AB Decreases Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by McAdam LLC - MarketBeat
NewEdge Advisors LLC Trims Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Coppell Advisory Solutions LLC - MarketBeat
Zurich Insurance Group Ltd FI Grows Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Woodline Partners LP - MarketBeat
Voleon Capital Management LP Cuts Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by Peloton Wealth Strategists - MarketBeat
Fred Alger Management LLC Buys 8,062 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Ascent Group LLC Trims Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Evercore ISI Cuts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $475.00 - MarketBeat
Vertex Pharmaceuticals: Buying The CF Fortress For The JOURNAVX Optionality (NASDAQ:VRTX) - Seeking Alpha
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by Focus Partners Wealth - MarketBeat
Belpointe Asset Management LLC Has $1.94 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Gotham Asset Management LLC Cuts Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Sepio Capital LP Purchases 1,311 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Fortis Capital Advisors LLC Makes New $850,000 Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Ilmarinen Mutual Pension Insurance Co Has $16.15 Million Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Plato Investment Management Ltd - MarketBeat
ToolGen and BarentsKrans step up CRISPR battle against Vertex - JUVE Patent
Curi RMB Capital LLC Has $204,000 Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Jacobs Levy Equity Management Inc. Buys Shares of 66,234 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
AQR Capital Management LLC Sells 99,914 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Scientists Awarded the 2025 Lasker~DeBakey Clinical Medical Research Award for Pioneering Discoveries in Cystic Fibrosis - Yahoo Finance
Alaethes Wealth LLC Makes New $1.48 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
Evercore ISI Adjusts PT on Vertex Pharmaceuticals to $475 From $510, Maintains Outperform Rating - MarketScreener
Polar Asset Management Partners Inc. Cuts Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $115.02 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade - ca.finance.yahoo.com
Is Vertex Pharmaceuticals Stock Underperforming the S&P 500? - MSN
5,953 Shares in Vertex Pharmaceuticals Incorporated $VRTX Purchased by United Services Automobile Association - MarketBeat
US Cystic Fibrosis Therapeutics Market Forecast and Company - GlobeNewswire
US Cystic Fibrosis Therapeutics Market Forecast and Company Analysis Report 2025-2033 Featuring Vertex, Abbvie, Novartis, Gilead Sciences, Viatris, Pfizer, AstraZeneca, and F. Hoffmann-La Roche - Yahoo Finance
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by EFG Asset Management North America Corp. - MarketBeat
Nissay Asset Management Corp Japan ADV Has $30.94 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex at Morgan Stanley Conference: Strategic Pipeline Expansion - Investing.com
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025 - GlobeNewswire Inc.
Healthcare Marketing Influencers 2025: Dr. Reshma Kewalramani - Medical Marketing and Media
Top Biotech Stocks To Watch NowSeptember 7th - MarketBeat
EP Wealth Advisors LLC Decreases Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Amundi Reduces Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Is There Enough Volume to Lift Vertex Pharmaceuticals IncorporatedIPO Watch & Stepwise Trade Signal Guides - beatles.ru
Vertex predicted to remain front and center of modest CF market growth - The Pharma Letter
2025 Vertex Foundation Scholarship recipients: Real stories and reimagined futures - Vertex Pharmaceuticals
Is Vertex Pharmaceuticals Stock Underperforming The S&P 500? - Barchart.com
0.57%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):